Morteza Naghavi

Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction

Background—Numerous studies have suggested that microbial agents may promote atherosclerosis. A smaller body of research has suggested that acute respiratory infection may be a risk factor for myocardial infarction (MI). We hypothesized that influenza vaccine might reduce the risk of recurrent MI in patients with documented coronary heart disease (CHD). Methods and Results—A case-control study was performed on 218 CHD patients seen at Memorial Hermann Hospital during the influenza season of October 1997 through March 1998. Patients who experienced new MI were included in the case group, and those who did not experience new MI or unstable angina were assigned to the control group. Data were collected by structured review of patients’ charts and through a subsequent telephone survey. Adjusted for history of influenza vaccination in previous years, multivariate logistic regression revealed risk of MI to be associated with current hypertension (OR 4.96, 95% CI 2.06 to 11.96, P <0.0001), hypercholesterolemia (OR 4.08, 95% CI 1.67 to 9.99, P =0.002), smoking (OR 3.75, 95% CI 1.76 to 7.98, P =0.001), and influenza vaccination (OR 0.33, 95% CI 0.13 to 0.82, P =0.017). Despite significant association in univariate analysis, multivitamin therapy and physical exercise were not associated with risk of reinfarction in multivariate analysis. Conclusions—In this study in patients with chronic CHD, vaccination against influenza was negatively associated with the development of new MI during the same influenza season. However, to address causal inference, examination of prospective data sets will be needed.

Application of IR and NIR fiber optic imaging in thermographic and spectroscopic diagnosis of atherosclerotic vulnerable plaques: preliminary experience

Despite major advances in cardiovascular science and technology during the past three decades, approximately half of all myocardial infarctions and sudden deaths occur unexpectedly. It is widely accepted that coronary atherosclerotic plaques and thrombotic complications resulting from their rupture or erosion are the underlying causes of this major health problem. The majority of these vulnerable plaques exhibit active inflammation, a large necrotic lipid core, a thin fibrous cap, and confer a stenosis of less than 70%. These lesions are not detectable by stress testing or coronary angiography. Our group is exploring the possibility of a functional classification based on physiological variables such as plaque temperature, pH, oxygen consumption, lactate production etc. We have shown that heat accurately locates the inflamed plaques. We also demonstrated human atherosclerotic plaques are heterogeneous with regard to pH and hot plaques and are more likely to be acidic. To develop a nonsurgical method for locating the inflamed plaques, we are developing both IR fiber optic imaging and NIR spectroscopic systems in our laboratory to detect hot and acidic plaque in atherosclerotic arterial walls. Our findings introduce the possibility of an isolated/combined IR and NIR fiber optic catheter that can bring new insight into functional assessment of atherosclerotic plaque and thereby detection of active and inflamed lesions responsible for heart attacks and strokes.

Digital (Fingertip) Thermal Monitoring of Vascular Function: A Novel, Noninvasive, Nonimaging Test to Improve Traditional Cardiovascular Risk Assessment and Monitoring of Response to Treatments

Digital thermal monitoring (DTM) is a noninvasive, inexpensive, easily performed, operator-independent vascular function test designed to complement the existing, risk-factor based assessment of vascular health and to monitor the vascular response to therapies. It is similar to a blood pressure device, with the addition of adhesive temperature probes on the right and left index fingertips that measure fingertip temperature fall and rebound during a brief (2–5 min), arm-cuff occlusion, and release procedure (reactive hyperemia). The higher the temperature rebound, the better the vascular reactivity. In our studies, we have found that DTM indices of vascular reactivity correlate strongly with the number of cardiovascular risk factors, measured by the Framingham Risk Score (FRS), and with the burden of asymptomatic (subclinical) coronary atherosclerosis, measured by coronary calcium score and CT angiography, as well as with myocardial perfusion defects on nuclear stress testing in symptomatic subjects. Moreover, our studies have shown that DTM provides incremental predictive value over risk factor assessment for the identification of high-risk patients with both subclinical atherosclerosis (Coronary Artery Calcium Score ≥100) and coronary artery stenosis (CT angiography showing ≥ 50% stenosis). Finally, DTM indices of vascular function have shown reproducibility comparable to blood pressure measurements. These very promising findings will require corroboration, particularly in long-term, prospective studies and clinical trials. It is important to emphasize that DTM is not intended to replace measurement of risk factors or advanced imaging tests. Rather, its purpose is to complement them by providing a powerful, noninvasive vascular function assessment of coronary health.